Physician profile
Trace Heavener
NPI 1841646726
$3,402.99
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2021: $583 · 2022: $837 · 2023: $1,727 · 2024: $98.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,109 · Travel and Lodging: $637 · Education: $79.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,109.08 |
| Travel and Lodging | $637.27 |
| Education | $79.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $998.01 | 2021-2024 | |
| Boston Scientific Corporation | $896.43 | 2022-2023 | Spyglass, Resolution Clip |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $336.72 | 2021-2024 | Xifaxan, Plenvu, Trulance |
| Janssen Biotech, INC. | $312.86 | 2021-2023 | Stelara, Simponi, Simponi Aria |
| Intercept Pharmaceuticals, INC. | $175.12 | 2021-2023 | Ocaliva |
| Takeda Pharmaceuticals U.S.A., INC. | $161.58 | 2021-2023 | Entyvio |
| Astrazeneca Pharmaceuticals LP | $119.78 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $112.71 | 2022 | |
| Ethicon US, LLC | $91.72 | 2021 | |
| Pentax of America, INC. | $35.31 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $31.74 | 2022-2023 | Dupixent |
| Fresenius Kabi USA, LLC | $29.27 | 2023 | Idacio |
| Lilly USA, LLC | $22.79 | 2024 | Omvoh |
| Novartis Pharmaceuticals Corporation | $20.03 | 2019 | |
| Merck Sharp & Dohme LLC | $17.10 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $15.21 | 2024 | Ibsrela |
| Celgene Corporation | $14.91 | 2023 | Zeposia |
| Braintree Laboratories, INC. | $11.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trace Heavener listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.